A controversial legal process turned this family’s tragedy into a nightmare—and it’s more common than you think

It’s a case that reveals the tragedies of guardianship: the loss of loved ones, painful legal battles, and so many impossible ...

Wendy Williams parties until midnight in New York City weeks after neurologist questions dementia diagnosis

In photos exclusively obtained by the Daily Mail, the former talk show host, 61, stepped out with her niece for a rare family ...

'Landman' Episode 4 Is Taylor Sheridan's Masterpiece

I can be hard on the Texas oil drama, but this is one of the TV creator's best episodes in a long time.
The News Minute

Dileep’s story: From mimicry artist to one of the most powerful men in Malayalam cinema

Barely visible behind the swarm of television cameras and the long microphones pushed at him, actor Dileep did not look calm.

From tax limits to free school meals: what Jersey's budget amendments mean for islanders

Budget debate begins, a total of 35 amendments have been lodged. ITV News breaks down how the biggest ones could impact ...

From AD to diehards, how Indiana fans spent 'one of the biggest days in IU history'

Packed bars, police escorts, chance encounters and jubilation: IndyStar followed how IU athletics figures, business owners ...
Arizona Daily Star

'One Battle After Another' leads Golden Globe nominations

"One Battle After Another" topped the Golden Globe nominations Monday, a victory for Warner Bros. just after Netflix struck a ...

Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...